2002
DOI: 10.3201/eid0810.020380
|View full text |Cite
|
Sign up to set email alerts
|

Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen

Abstract: The bioterrorism-associated human anthrax epidemic in the fall of 2001 highlighted the need for a sensitive, reproducible, and specific laboratory test for the confirmatory diagnosis of human anthrax. The Centers for Disease Control and Prevention developed, optimized, and rapidly qualified an enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G (IgG) antibodies to Bacillus anthracis protective antigen (PA) in human serum. The qualified ELISA had a minimum detection limit of 0.06 µg/mL, a reliable lo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
164
1

Year Published

2003
2003
2015
2015

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 192 publications
(168 citation statements)
references
References 27 publications
3
164
1
Order By: Relevance
“…A serum concentration of IgG to PA ≥ 3 g/mL was observed in all subjects after vaccination. This level of antibody, which represents the lower limit of quantification for undiluted serum using an ELISA analogous to that applied in this study [9], was reached by 39.5% of subjects after the first injection, by a total of 96.5% after the second injection, and by 100% after the third injection ( Table 4). The mean number of days after the first vaccine dose needed to reach 3 g/mL was 24.2 (range = 13-63 days).…”
Section: Igg To Pamentioning
confidence: 63%
See 1 more Smart Citation
“…A serum concentration of IgG to PA ≥ 3 g/mL was observed in all subjects after vaccination. This level of antibody, which represents the lower limit of quantification for undiluted serum using an ELISA analogous to that applied in this study [9], was reached by 39.5% of subjects after the first injection, by a total of 96.5% after the second injection, and by 100% after the third injection ( Table 4). The mean number of days after the first vaccine dose needed to reach 3 g/mL was 24.2 (range = 13-63 days).…”
Section: Igg To Pamentioning
confidence: 63%
“…Optical density (OD) values were read within 30 min by using a Bio-Tek ELx808 plate with 405 and 490 nm filters, and KC4 software (Bio-Tek Instruments, Inc., Winooski, VT). OD values were converted to immunoglobulin concentration ( g/mL) by using a standard curve calibration factor [9]. Titers were calculated as the reciprocal of the highest dilution of the test serum yielding a mean OD value ≥ the cut-off value for the assay.…”
Section: Laboratory Studiesmentioning
confidence: 99%
“…Serology and reverse transcription (RT)-PCR were performed by other laboratories at CDC. [42][43][44] § Contained a small, superficial, shave biopsy that was inadequate for pathologic evaluation.…”
Section: Methodsmentioning
confidence: 99%
“…for standard reference serum AVR801 was used to determine the concentration of anti-PA IgG in lg/mL of test serum; the lower limit of quantification of the anti-PA ELISA was 3.7 mg/mL anti-PA IgG in undiluted serum samples; diagnostic sensitivity was 98.6% and diagnostic specificity was 98.4% (Quinn et al 2002(Quinn et al , 2004Semenova et al 2004) Anti-PA IgG concentration ‡ to the assay lower limit of quantification (3.7 lg/mL)…”
Section: Study Populationmentioning
confidence: 99%
“…Pathogens tested and specific methods of serologic testing for each of the agents evaluated have been described elsewhere (Table 1; Lindsey et al 1976;Dikken and Kmety 1978;Brown et al 1981;Dalton et al 1995;Plikaytis et al 1996;Nicholson et al 1997;Johnson et al 2000Johnson et al , 2005Martin et al 2000;Quinn et al 2002Quinn et al , 2004Dumler 2004;Semenova et al 2004;Jones et al 2007). Baseline seropositivity was interpreted as prior infection.…”
Section: Serological Testingmentioning
confidence: 99%